Clinical Trial Update: Research on Early Diagnosis and Risk Stratification Biomarkers of Anti-Tumor Drug-Associated Interstitial Pneumonia Driven by Multi-Omics Integration

View source ↗

Summary

This clinical trial is investigating early diagnosis and risk stratification biomarkers for anti-tumor drug–associated interstitial pneumonia using multi-omics …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Interstitial Lung Disease
• Interstitial Pneumonia

Snippet

Sponsor: Fuzhou University Affiliated Provincial Hospital | Conditions: Anti-Tumor Drug-Associated Interstitial Pneumonia | Status: NOT_YET_RECRUITING